Nature Medicine Publishes Results from Two Registration Studies of AYVAKIT® (avapritinib) Showing Sustained Benefits in Patients with Advanced Systemic Mastocytosis December 6, 2021
CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients December 6, 2021
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications December 2, 2021
Independence Health Group and Quartet Health Announce Strategic Partnership to Drive Speed to Mental Health Care December 2, 2021
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications December 2, 2021
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results December 2, 2021
AviadoBio™ Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform December 2, 2021
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) December 1, 2021
Surface Oncology Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG December 1, 2021
Ultragenyx Announces First Patient Dosed in Phase 1/2 Clinical Study of UX053, an mRNA Therapy for the Treatment of Glycogen Storage Disease Type III December 1, 2021